In addition, 51 shows a considerable selectivity profile for c-Met over other kinases (FLT3, VEGFR2 and EGFR) and exerts significant inhibitory activities against diverse types of tumor cells through arresting the cell cycle in the G2/M-phase inducing cell apoptosis. This evidence concerns the gene KDR and neoplasm.